Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab Withdrawal in Sarcoidosis
NCT05689879Phase 3Active, not recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2023
- Primary completion
- Jan 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in sarcoidosis, sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2023; status: active, not recruiting.
02
Drugs
infliximab
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on NCT05689879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05689879.